This is a past event. Registration is closed. View other Parenteral Drug Association - Asia Pacific office events.

The webinar will raise out the contamination sources in parenteral drug packaging and will discuss how to overcome these challenges using QbD approach in manufacturing to meet expectations of Annex 1.

Pharmaceutical regulations are evolving and with the evolution, there is a need for parenteral packaging manufacturers to meet the demands. The webinar will focus on latest trends in pharmaceutical industry and regulations. It will help you understand the challenges and common concerns and how these concerns can be addressed by having a Quality-by-design (Qbd) approach for manufacturing of parenteral packaging components. The presentation will also focus on expectations of Annex 1 and supplier perspective towards it in context of contamination control strategy and component selection.


  • Understand challenges and common concerns in pharmaceutical industry
  • Sources of contamination in pharmaceutical elastomer manufacturing
  • Discuss how the focus on manufacturing with the help of Qbd approach can help to overcome the concerns
  • Elastomeric manufacturing process using Qbd approach to meet Annex 1 expectations

This webinar will be of interest to the following audiences:

  • Packaging Developers
  • Formulation Scientists
  • Analytical Chemists
  • Quality Assurance
  • New Product Marketing Managers / Directors
  • Project Managers
  • Operations Managers

Sponsors and Partners